Physician profile
Ram Kalus
NPI 1922172980
$9,196.89
in general payments reported to CMS, 2019-2025
21 companies · $1,300 in 2025
The $1,300 reported for 2025 was more than what 78% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,989 · 2020: $606 · 2021: $1,724 · 2022: $776 · 2023: $965 · 2024: $1,839 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,562 · Travel and Lodging: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,561.93 |
| Travel and Lodging | $540.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,814.69 | 2019-2022 | |
| Mentor Worldwide LLC | $1,738.17 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $731.30 | 2019-2025 | |
| Stryker Corporation | $503.19 | 2024 | Na |
| Tepha INC | $478.36 | 2019 | |
| Smith+Nephew, INC. | $442.20 | 2023-2025 | Stravix, Grafix Pl, Pico |
| Tela Bio, INC. | $413.20 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $388.72 | 2023-2025 | |
| Sanara Medtech INC. | $311.24 | 2020-2025 | Celleraterx, Celleraterx |
| Integra Lifesciences Corporation | $303.58 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Merz North America, INC. | $300.16 | 2021-2024 | |
| Medtronic, INC. | $226.67 | 2024 | Plasmablade(Tm) |
| Axogen | $179.49 | 2023-2025 | Avance Nerve Graft |
| Acera Surgical, INC. | $105.73 | 2023 | Restrata Wound Matrix |
| Sientra, INC. | $92.29 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $70.79 | 2022-2024 | |
| Davol INC. | $28.10 | 2024 | Phasix Mesh |
| Kerecis Limited | $22.92 | 2019 | |
| Motiva USA, LLC | $17.87 | 2025 | |
| Coopersurgical, INC. | $14.78 | 2023 | Wallach Cryosurgical Equipment |
| Tei Biosciences INC | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ram Kalus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.